Literature DB >> 28321519

Cardiac autonomic function in type 1 and type 2 myotonic dystrophy.

Piotr Bienias1, Anna Łusakowska2, Michał Ciurzyński3, Zuzanna Rymarczyk3, Katarzyna Irzyk3, Michał Konwerski4, Kamil Ciąpała4, Paweł Kowalski4, Anna Kamińska2, Piotr Pruszczyk3.   

Abstract

OBJECTIVE: The aim of this study was to evaluate cardiac autonomic nervous system function using Holter-derived and standard electrocardiographic parameters in patients with myotonic dystrophy (dystrophia myotonica, DM) and no clinically overt heart involvement.
METHODS: Eighty-four DM patients without conditions potentially influencing cardiac autonomic function were enrolled in the study: 44 with DM type 1 and 40 with DM type 2 (mean age 34.9 ± 11.5 and 47.8 ± 13.5 years, respectively). Two corresponding control groups of aged-matched healthy subjects were selected for DM1 (n = 35) and for DM2 (n = 30). Standard electrocardiography for QT interval dispersion and 24-h Holter monitoring with time-domain heart rate variability and heart rate turbulence were performed.
RESULTS: No significant differences in time-domain heart rate variability parameters between DM1 or DM2 subjects and controls were observed. However, heart rate turbulence parameters were significantly impaired in DM1 patients as compared to their controls: turbulence onset (p = 0.025), and turbulence slope (p = 0.018). Moreover, turbulence slope was also impaired in DM2 patients (p = 0.042). As compared to controls, we observed an increased QT dispersion, both in DM1 (p = 0.003) and also in DM2 patients (p < 0.0001). No relationship between disease duration or neurological status and time-domain heart rate variability, heart rate turbulence, and QT dispersion was observed.
INTERPRETATION: Despite normal time-domain heart rate parameters, impaired heart rate turbulence and increased QT dispersion may suggest cardiac autonomic nervous system dysfunction in DM patients. The present study is the first one in which heart rate turbulence and QT dispersion assessment were examined both in DM1 and DM2 patients.

Entities:  

Keywords:  Heart rate turbulence; Heart rate variability; Myotonic dystrophy type 1; Myotonic dystrophy type 2; QT dispersion

Mesh:

Year:  2017        PMID: 28321519     DOI: 10.1007/s10286-017-0413-y

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  32 in total

1.  Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction.

Authors:  G Schmidt; M Malik; P Barthel; R Schneider; K Ulm; L Rolnitzky; A J Camm; J T Bigger; A Schömig
Journal:  Lancet       Date:  1999-04-24       Impact factor: 79.321

2.  Myocardial repolarization dispersion and autonomic nerve activity in a canine experimental acute myocardial infarction model.

Authors:  Gianfranco Piccirillo; Federica Moscucci; Gaetana D'Alessandro; Matteo Pascucci; Pietro Rossi; Seongwook Han; Lan S Chen; Shien-Fong Lin; Peng-Sheng Chen; Damiano Magrì
Journal:  Heart Rhythm       Date:  2013-10-09       Impact factor: 6.343

3.  Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

Authors: 
Journal:  Eur Heart J       Date:  1996-03       Impact factor: 29.983

4.  Increased temporal dispersion of myocardial repolarization in myotonic dystrophy type 1: beyond the cardiac conduction system.

Authors:  Damiano Magrì; Gianfranco Piccirillo; Elisabetta Bucci; Giulia Pignatelli; Filippo Maria Cauti; Stefania Morino; Pamela Latino; Daria Santini; Federica Marrara; Massimo Volpe; Giovanni Antonini; Marco Testa
Journal:  Int J Cardiol       Date:  2010-11-26       Impact factor: 4.164

5.  ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.

Authors:  Douglas P Zipes; A John Camm; Martin Borggrefe; Alfred E Buxton; Bernard Chaitman; Martin Fromer; Gabriel Gregoratos; George Klein; Arthur J Moss; Robert J Myerburg; Silvia G Priori; Miguel A Quinones; Dan M Roden; Michael J Silka; Cynthia Tracy; Jean-Jacques Blanc; Andrzej Budaj; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; Juan Luis Tamargo; José Luis Zamorano; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Elliott M Antman; Jeffrey L Anderson; Sharon A Hunt; Jonathan L Halperin; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Eur Heart J       Date:  2006-09       Impact factor: 29.983

6.  Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy.

Authors:  J Mathieu; H Boivin; D Meunier; M Gaudreault; P Bégin
Journal:  Neurology       Date:  2001-02-13       Impact factor: 9.910

Review 7.  Heart rate turbulence.

Authors:  Iwona Cygankiewicz
Journal:  Prog Cardiovasc Dis       Date:  2013-08-29       Impact factor: 8.194

8.  Assessment of cardiovascular autonomic function in myotonic dystrophy type 2 (DM2/PROMM).

Authors:  Peter Flachenecker; Christiane Schneider; Simone Cursiefen; Kenneth Ricker; Klaus V Toyka; Karlheinz Reiners
Journal:  Neuromuscul Disord       Date:  2003-05       Impact factor: 4.296

9.  Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy.

Authors:  Robert Breton; Jean Mathieu
Journal:  Can J Cardiol       Date:  2009-02       Impact factor: 5.223

Review 10.  Sudden cardiac death in neuromuscular disorders.

Authors:  Josef Finsterer; Claudia Stöllberger; Concha Maeztu
Journal:  Int J Cardiol       Date:  2015-10-28       Impact factor: 4.164

View more
  3 in total

1.  The purpose of heart rate variability measurements.

Authors:  Marek Malik; Heikki Huikuri; Federico Lombardi; Georg Schmidt
Journal:  Clin Auton Res       Date:  2017-03-27       Impact factor: 4.435

2.  Arrhythmic risk evaluation in myotonic dystrophy: the importance of selection criteria and methodological approach.

Authors:  Vincenzo Russo; Andrea Antonio Papa; Anna Rago; Gerardo Nigro
Journal:  Clin Auton Res       Date:  2017-04-27       Impact factor: 4.435

Review 3.  Modeling of Myotonic Dystrophy Cardiac Phenotypes in Drosophila.

Authors:  Mouli Chakraborty; Beatriz Llamusi; Ruben Artero
Journal:  Front Neurol       Date:  2018-07-16       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.